Cronos Group reports Q1 EPS 2c vs. (1c) last year

Reports Q1 revenue $32.3M vs. $25.3M last yea. r”2025 is shaping up to be a transformative year for Cronos as we execute our strategic priorities to drive revenue growth, expand margins, and maintain disciplined cost management. While strong demand for our flower products has recently outpaced supply, we are confident that our Cronos GrowCo expansion, on track for completion in the second quarter with initial sales in the second half of the year, will unlock significant capacity to meet this demand and fuel our next phase of growth,” said Mike Gorenstein, Chairman, President and CEO of Cronos. “Our brands continue to lead in key categories, with Spinach solidifying its position as a top performer in Canada #1 in edibles, #3 in flower, #4 in vapes and top-ten in pre-rolls. Internationally, PEACE NATURALS is setting records in Israel, posting record net revenue in the quarter and retaining its #1 market share. This achievement is a reflection of our long-term commitment to the market and the dedication of our team in Israel, as well as a validation of Cronos’ approach to borderless products leveraging the Company’s extensive investments in genetics, breeding, research and development, and product development. The PEACE NATURALS brand continues to gain traction in Germany and the UK as well. With our unmatched balance sheet, relentless focus on innovation, and disciplined global expansion, Cronos is uniquely positioned to capitalize on growth opportunities in the global cannabis industry and to deliver sustained value for our shareholders.”